Advanced Cardiac Therapeutics Company Profile

09:51 EDT 22nd March 2018 | BioPortfolio

Headquartered in Laguna Beach, California, USA, ACT specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology based on microwave radiometry.

News Articles [1566 Associated News Articles listed on BioPortfolio]

Advanced Cardiac Life Support Updates

The American Heart Association Advanced Cardiac Life Support guidelines are recognized as the authoritative reference for acute cardiopulmonary resuscitation. Emergency medicine providers should be th...

Living too far from advanced cardiac care decreases your odds of survival

(Elsevier) A new study published in the Canadian Journal of Cardiology determined that patients with acute cardiac syndrome (ACS) and cardiogenic shock (CS), who live far from the only cardiac cathete...

Sex Rarely Causes Cardiac Arrest, Even in Cardiac Patients – Medscape

MedscapeSex Rarely Causes Cardiac Arrest, Even in Cardiac PatientsMedscapeANAHEIM, CA — Sexual activity is rarely the cause of sudden cardiac arrest, a new study suggests. Specifically, in more than...

Cardiac MRI Most Valuable Test for Diagnosis and Prognosis in Cardiac Sarcoidosis

Among patients with extracardiac sarcoidosis, cardiac MRI was the best test for diagnosing cardiac involvement and the strongest independent predictor of adverse outcomes.

Computer app alerts physicians to patient's risk of advanced HF

An extensive computer app developed by researchers in Salt Lake City, Utah, could significantly improve both the quality and lon

Sex unlikely to cause cardiac arrest, study finds – BBC News

BBC NewsSex unlikely to cause cardiac arrest, study findsBBC NewsSudden cardiac arrest is associated with sexual activity far more often in men than women, research suggests. But sex is a rare trigger...

High-Sensitivity Cardiac Troponin I and Cardiac Outcomes in Suspected ACS

This systematic review evaluates the performance of a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients with suspected acute coronary syndrome.

Timing of Cardiac Arrest May Affect Survival

TUESDAY, Jan. 23, 2018 -- Survival rates are rising for people who have cardiac arrest while in the hospital, a new study finds. But if cardiac arrest happens at night or on a weekend, you're more lik...

PubMed Articles [3142 Associated PubMed Articles listed on BioPortfolio]

The Introduction and Clinical Use of Cardiac-Specific Troponin Assays.

The earliest biomarkers introduced to diagnose myocardial infarction (MI) such as aspartate aminotransferase (AST) and lactic dehydrogenase (LDH) lacked cardiac specificity and were replaced by creati...

Advanced cardiac imaging techniques assist in characterizing a cardiac mass and directing management.

Advanced imaging techniques, including contrast echocardiography and CMR, provided valuable characterization and evaluation of a boy with an unusual cardiac mass. Imaging features assisted with differ...

Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.

The soluble receptor for advanced glycation end products (sRAGE) has been implicated in diabetic vascular complications. We have examined the association between sRAGE and cardiac markers [NT-proBNP a...

Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium.

Despite therapeutic advances that have prolonged life, myocardial infarction (MI) remains a leading cause of death worldwide and imparts a significant economic burden. The advancement of treatments to...

Patterns of Resuscitation Care and Survival After In-Hospital Cardiac Arrest in Patients With Advanced Cancer.

Little is known regarding patterns of resuscitation care in patients with advanced cancer who suffer in-hospital cardiac arrest (IHCA).

Clinical Trials [7134 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumorsfor

T-1101 is a novel anti-cancer agent being developed by Taivex Therapeutics Corporation, and is being studied in a phase I dose escalation trial, protocol TAI-001. That trial's primary aim ...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [2280 Associated Companies listed on BioPortfolio]

Advanced Cardiac Therapeutics, Inc.

Headquartered in Laguna Beach, Calif., privately held Advanced Cardiac Therapeutics, Inc. specializes in advanced irrigated cardiac catheter ablation systems with proprietary temp...

Advanced Cardiac Therapeutics

Headquartered in Laguna Beach, California, USA, ACT specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology based on microwave radiometr...

Cardiac Insight, Inc.

Cardiac Insight, Inc. ( is a U.S. developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex ...

Medicomp, Inc.

Medicomp, Inc., founded in 1981, designs, develops and provides advanced cardiac monitoring products and services using the most sophisticated and reliable ambulatory heart-monitoring systems availabl...


Research and development of therapeutics based on signaling pathways in cardiac, hypertrophy, myosin heavy chain research and gene/protein expression profiling using its human cardiac tissue bank.

More Information about "Advanced Cardiac Therapeutics" on BioPortfolio

We have published hundreds of Advanced Cardiac Therapeutics news stories on BioPortfolio along with dozens of Advanced Cardiac Therapeutics Clinical Trials and PubMed Articles about Advanced Cardiac Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Cardiac Therapeutics Companies in our database. You can also find out about relevant Advanced Cardiac Therapeutics Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record